Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Depreciation & Amortization (CF) (2020 - 2025)

Ovid Therapeutics' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $17000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 89.38% year-over-year to $17000.0; the TTM value through Dec 2025 reached $273000.0, down 55.46%, while the annual FY2025 figure was $273000.0, 55.46% down from the prior year.
  • Depreciation & Amortization (CF) reached $17000.0 in Q4 2025 per OVID's latest filing, up from $16000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $184980.0 in Q4 2022 to a low of $16000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 5 years is $110179.2, with a median of $136500.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 224.81% in 2022, then plummeted 90.53% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $56951.0 in 2021, then surged by 224.81% to $184980.0 in 2022, then fell by 24.32% to $140000.0 in 2023, then grew by 14.29% to $160000.0 in 2024, then crashed by 89.38% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for OVID's Depreciation & Amortization (CF) are $17000.0 (Q4 2025), $16000.0 (Q3 2025), and $99000.0 (Q2 2025).